Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs’ Clinical Advisory Board
AUCKLAND, New Zealand, Feb. 15, 2023 /PRNewswire/ -- Formus Labs, creator of the first automated 3D AI-enabled pre-operative planner for joint replacement surgeries, today announces that arthroplasty experts Dr J. Bohannon Mason, Dr. Atul Kamath, and Dr. James A. Germano will join its clinical advisory and development board to help shape the next...
Kubota Tractor Corporation Implements Syncron For Streamlined Retail Inventory Management and Exceptional Dealer Network Service
Leading distributor of agricultural and construction machinery equipment selects Syncron Retail Inventory for optimized dealer inventory management that aligns aftermarket strategies with dealer networks for superior customer service. CHICAGO, Feb. 15, 2023 /PRNewswire/ -- Syncron today announced that Kubota Tractor Corporation, a United States distributor of agricultural and construction machinery equipment,...
Flagship Biosciences Applauded by Frost & Sullivan for Changing Biomarker Analysis to Find Biomarkers that Aid Drug Development and Diagnostics
Digital pathology solutions are increasingly used in the preclinical and clinical development phases, particularly toxicologic pathology and clinical trials, speeding up the process and curtailing expenses. SAN ANTONIO, Feb. 15, 2023 /PRNewswire/ -- Frost & Sullivan assessed the artificial intelligence (AI)-enabled digital pathology solutions industry, and based on its findings, recognizes Flagship...
Henlius Announces U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar Trastuzumab HLX02
The first Chinese biosimilar approved in both China and the EU, and potentially to be approved in the U.S. - HLX02 (trastuzumab for injection, trade name in China: HANQUYOU; trade name in Europe: Zercepac®; trade names in Australia: Tuzucip® and Trastucip®) has been approved in more than 30 countries - As the product footprint expands into more countries,...
Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System
SHENZHEN, China, Feb. 15, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), one of the world's leading developers and providers of advanced medical devices and solutions, recently launched its first wireless handheld ultrasound system, the TE Air. Wireless handheld ultrasound system, TE Air, Innovation Untethered "Built from Mindray's leading technologies, the TE Air has made...
Towards Inexpensive and Highly Conductive Anion-Exchange Membranes: WPI-MANA
TSUKUBA, Japan, Feb. 15, 2023 /PRNewswire/ -- An international research team at the International Center for Materials Nanoarchitectonics (WPI-MANA) has worked to improve the ionic conductivity of anion-exchange membranes (AEMs) made from layered double hydroxides (LDHs), laying the foundation for their use in many electrochemical applications. (Image: https://kyodonewsprwire.jp/prwfile/release/M105739/202302032656/_prw_PI1fl_5tT8FF5G.jpg) LDHs are inorganic compounds that can be made into extremely thin...
GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS
- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with DAA Therapies - Review of implementation science projects toward HCV Elimination by 2030 in Asia proved effective in improving patient outcomes - Efficacy and safety demonstrated with Bictegravir/Emtricitabine/Tenofovir Alafenamide as...
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
ROCKVILLE, Md. and SUZHOU, China, Feb. 15, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first patient with thyroid associated ophthalmopathy (TAO) has been successfully dosed in the Phase 2 study of IBI311, a...
Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)
Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is proud to announce that dosing has commenced in the Phase 1 first-in-human trial for KIO-301. This trial...
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine
MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the successful completion of its joint research project conducted with Heidelberg University Hospital (UKHD) under the Research Cooperation Agreement announced in February 2021. The aim of this project was to create and validate a generator-based theranostic...
